Clinical Trial Update: Enpowering Progression Risk of Cerebral Amyloid Angiopathy

View source ↗

Summary

A completed clinical trial assessing factors related to progression risk in cerebral amyloid angiopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Amyloid Angiopathy

Snippet

Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta | Conditions: Cerebral Amyloid Angiopathy, CAA - Cerebral Amyloid Angiopathy | Status: COMPLETED